111 related articles for article (PubMed ID: 27653446)
41. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
42. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
43. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
McKenney JK; Longacre TA
Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
[TBL] [Abstract][Full Text] [Related]
44. The contribution of hysteroscopy to the detection malignancy in symptomatic postmenopausal women.
Liberis V; Tsikouras P; Christos Z; Ammari A; Dislian V; Koutlaki N; Liberis A; Maroulis G
Minim Invasive Ther Allied Technol; 2010 Apr; 19(2):83-93. PubMed ID: 20158408
[TBL] [Abstract][Full Text] [Related]
45. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
Garuti G; Mirra M; Luerti M
J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
[TBL] [Abstract][Full Text] [Related]
46. The Diagnostic Value of Routine Papanicolaou Smears for Detecting Endometrial Cancers: An Update.
Lai CR; Hsu CY; Hang JF; Li AF
Acta Cytol; 2015; 59(4):315-8. PubMed ID: 26315394
[TBL] [Abstract][Full Text] [Related]
47. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
Qian J; Weber D; Cochran R; Hossain D; Bostwick DG
Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199
[TBL] [Abstract][Full Text] [Related]
48. Ultrasound assessment of endometrial morphology and vascularity to predict endometrial malignancy in women with postmenopausal bleeding and sonographic endometrial thickness >or= 4.5 mm.
Opolskiene G; Sladkevicius P; Valentin L
Ultrasound Obstet Gynecol; 2007 Sep; 30(3):332-40. PubMed ID: 17688304
[TBL] [Abstract][Full Text] [Related]
49. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
50. Increased risk of malignancy for non-atypical urothelial cell groups compared to negative cytology in voided urine. Morphological changes with LBC.
Granados R; Butrón M; Santonja C; Rodríguez JM; Martín A; Duarte J; Camarmo E; Corrales T; Aramburu JA
Diagn Cytopathol; 2016 Jul; 44(7):582-90. PubMed ID: 27089849
[TBL] [Abstract][Full Text] [Related]
51. Combining endometrium sampling device and SurePath preparation to screen for endometrial carcinoma: a validation study.
Wen J; Chen R; Zhao J; Dong Y; Yang X; Liao QP
Chin Med J (Engl); 2015 Mar; 128(5):648-53. PubMed ID: 25698198
[TBL] [Abstract][Full Text] [Related]
52. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments.
Norimatsu Y; Shimizu K; Kobayashi TK; Moriya T; Tsukayama C; Miyake Y; Ohno E
Cancer; 2006 Apr; 108(2):77-85. PubMed ID: 16463402
[TBL] [Abstract][Full Text] [Related]
53. Risk and predictors of malignancy in women with endometrial polyps.
Wethington SL; Herzog TJ; Burke WM; Sun X; Lerner JP; Lewin SN; Wright JD
Ann Surg Oncol; 2011 Dec; 18(13):3819-23. PubMed ID: 21701931
[TBL] [Abstract][Full Text] [Related]
54. Endometrial Adenocarcinoma in SurePath™ Cervical Samples: Cytological Features Revisited.
Gupta N; Crossley J; Dudding N; Smith JH
Acta Cytol; 2016; 60(1):46-52. PubMed ID: 26934466
[TBL] [Abstract][Full Text] [Related]
55. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance.
Nucci MR; Prasad CJ; Crum CP; Mutter GL
Mod Pathol; 1999 Dec; 12(12):1137-42. PubMed ID: 10619266
[TBL] [Abstract][Full Text] [Related]
56. Three-dimensional ultrasound imaging for discrimination between benign and malignant endometrium in women with postmenopausal bleeding and sonographic endometrial thickness of at least 4.5 mm.
Opolskiene G; Sladkevicius P; Jokubkiene L; Valentin L
Ultrasound Obstet Gynecol; 2010 Jan; 35(1):94-102. PubMed ID: 19902471
[TBL] [Abstract][Full Text] [Related]
57. Bethesda System reporting rates for conventional Papanicolaou tests and liquid-based cytology in a large Chinese, College of American Pathologists-certified independent medical laboratory: analysis of 1394389 Papanicolaou test reports.
Zheng B; Austin RM; Liang X; Li Z; Chen C; Yan S; Zhao C
Arch Pathol Lab Med; 2015 Mar; 139(3):373-7. PubMed ID: 25724034
[TBL] [Abstract][Full Text] [Related]
58. [On-site fine-needle aspiration cytology of thyroid nodules. Quality assurance of the Bethesda System for Reporting Thyroid Cytopathology (2008)].
Bak M; Péter I; Nyári T; Simon P; Újlaky M; Boér A; Kásler M
Orv Hetil; 2015 Oct; 156(41):1661-6. PubMed ID: 26551169
[TBL] [Abstract][Full Text] [Related]
59. Prediction of histological types of endometrial cancer by endometrial cytology.
Okadome M; Saito T; Nishiyama N; Ariyoshi K; Shimamoto K; Shimada T; Kodama K; Imamura S; Nishiyama K; Taguchi K
J Obstet Gynaecol Res; 2014 Jul; 40(7):1931-9. PubMed ID: 25056473
[TBL] [Abstract][Full Text] [Related]
60. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
